Genetic and phenotypic spectrum of non-21-hydroxylase-deficiency primary adrenal insufficiency in childhood: data from 111 Chinese patients

被引:2
作者
Duan, Ying [1 ]
Zheng, Wanqi [1 ]
Xia, Yu [1 ]
Zhang, Huiwen [1 ]
Liang, Lili [1 ]
Wang, Ruifang [1 ]
Yang, Yi [1 ]
Zhang, Kaichuang [1 ]
Lu, Deyun [1 ]
Sun, Yuning [1 ]
Han, Lianshu [1 ]
Yu, Yongguo [2 ]
Gu, Xuefan [1 ]
Sun, Yu [2 ]
Xiao, Bing [2 ]
Qiu, Wenjuan [1 ,3 ]
机构
[1] Affiliated Shanghai Jiaotong Univ, Shanghai Inst Pediat Res, Dept Pediat Endocrinol & Genet Metab, Xinhua Hosp,Sch Med, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Inst Pediat Res, Clin Genet Ctr, Dept Pediat Endocrinol & Genet Metab,Xinhua Hosp,S, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Shanghai 200082, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
Paediatrics; Gene Frequency; Adrenal Gland Diseases; Diagnosis; Phenotype; JOINT CONSENSUS RECOMMENDATION; ACUTE REGULATORY PROTEIN; MEDICAL GENETICS; AMERICAN-COLLEGE; DIAGNOSIS; MUTATIONS; MANAGEMENT; DEFICIENCY; VARIANTS; ADRENOLEUKODYSTROPHY;
D O I
10.1136/jmg-2022-108952
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundPrimary adrenal insufficiency (PAI) is a rare but life-threatening condition. Differential diagnosis of numerous causes of PAI requires a thorough understanding of the condition. MethodsTo describe the genetic composition and presentations of PAI. The following data were collected retrospectively from 111 patients with non-21OHD with defined genetic diagnoses: demographic information, onset age, clinical manifestations, laboratory findings and genetic results. Patients were divided into four groups based on the underlying pathogenesis: (1) impaired steroidogenesis, (2) adrenal hypoplasia, (3) resistance to adrenocorticotropic hormone (ACTH) and (4) adrenal destruction. The age of onset was compared within the groups. ResultsMutations in the following genes were identified: NR0B1 (n=39), STAR (n=33), CYP11B1 (n=12), ABCD1 (n=8), CYP17A1 (n=5), HSD3B2 (n=4), POR (n=4), MRAP (n=2), MC2R (n=1), CYP11A1 (n=1), LIPA (n=1) and SAMD9 (n=1). Frequent clinical manifestations included hyperpigmentation (73.0%), dehydration (49.5%), vomiting (37.8%) and abnormal external genitalia (23.4%). Patients with adrenal hypoplasia typically presented manifestations earlier than those with adrenal destruction but later than those with impaired steroidogenesis (both p<0.01). The elevated ACTH (92.6%) and decreased cortisol (73.5%) were the most common laboratory findings. We generated a differential diagnosis flowchart for PAI using the following clinical features: 17-hydroxyprogesterone, very-long-chain fatty acid, external genitalia, hypertension and skeletal malformation. This flowchart identified 84.8% of patients with PAI before next-generation DNA sequencing. ConclusionsSTAR and NR0B1 were the most frequently mutated genes in patients with non-21OHD PAI. Age of onset and clinical characteristics were dependent on aetiology. Combining clinical features and molecular tests facilitates accurate diagnosis.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 44 条
  • [21] Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler Syndrome and disordered steroidogenesis
    Huang, NW
    Pandey, AV
    Agrawal, V
    Reardon, W
    Lapunzina, PD
    Mowat, D
    Jabs, EW
    Van Vliet, G
    Sack, J
    Flück, CE
    Miller, WL
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (05) : 729 - 749
  • [22] Identification of five novel STAR variants in ten Chinese patients with congenital lipoid adrenal hyperplasia
    Huang, Zhuo
    Ye, Jun
    Han, Lianshu
    Qiu, Wenjuan
    Zhang, Huiwen
    Yu, Yongguo
    Liang, Lili
    Gong, Zhuwen
    Gu, Xuefan
    [J]. STEROIDS, 2016, 108 : 85 - 91
  • [23] Clinical Features of 57 Patients with Lipoid Congenital Adrenal Hyperplasia: Criteria for Nonclassic Form Revisited
    Ishii, Tomohiro
    Tajima, Toshihiro
    Kashimada, Kenichi
    Mukai, Tokuo
    Tanahashi, Yusuke
    Katsumata, Noriyuki
    Kanno, Junko
    Hamajima, Takashi
    Miyako, Kenichi
    Ida, Shinobu
    Hasegawa, Tomonobu
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (11) : 1 - 9
  • [24] Mutation Spectrum of STAR and the Founder Effect of p.Q258*in Korean Patients with Congenital Lipoid Adrenal Hyperplasia
    Kang, Eungu
    Kim, Yoon-Myung
    Kim, Gu-Hwan
    Lee, Beom Hee
    Yoo, Han-Wook
    Choi, Jin-Ho
    [J]. MOLECULAR MEDICINE, 2017, 23 : 149 - 154
  • [25] Primary adrenal insufficiency in children: Diagnosis and management
    Kirkgoz, Tarik
    Fellow, Clinical
    Guran, Tulay
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 32 (04) : 397 - 424
  • [26] Krone Nils, 2005, Hum Mutat, V25, P502, DOI 10.1002/humu.9331
  • [27] Li Zhilan, 2021, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V46, P780, DOI 10.11817/j.issn.1672-7347.2021.200758
  • [28] ROLE OF STEROIDOGENIC ACUTE REGULATORY PROTEIN IN ADRENAL AND GONADAL STEROIDOGENESIS
    LIN, D
    SUGAWARA, T
    STRAUSS, JF
    CLARK, BJ
    STOCCO, DM
    SAENGER, P
    ROGOL, A
    MILLER, WL
    [J]. SCIENCE, 1995, 267 (5205) : 1828 - 1831
  • [29] Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia
    Lin, Lin
    Hindmarsh, Peter C.
    Metherell, Louise A.
    Alzyoud, Mahmoud
    Al-Ali, Maryam
    Brain, Caroline E.
    Clark, Adrian J. L.
    Dattani, Mehul T.
    Achermann, John C.
    [J]. CLINICAL ENDOCRINOLOGY, 2007, 66 (02) : 205 - 210
  • [30] Novel Insight into Etiology, Diagnosis and Management of Primary Adrenal Insufficiency
    Malikova, Jana
    Flueck, Christa E.
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2014, 82 (03): : 145 - 157